AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Oxybutynin Chloride
9 registrations across 2 African markets— 6 active
Markets with Oxybutynin Chloride
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OXYSPAS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| LYRINEL 5 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | suspended | Oct 2022 |
| LYRINEL 10 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | suspended | Oct 2022 |
| LENDITRO | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| DITROPAN | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| OXYREST | 🇿🇦South Africa | iPharma (Pty) Ltd | active | Jan 1900 |
| CIPLA-OXYBUTYNIN CHLORIDE | 🇿🇦South Africa | CIPLA LIFE SCIENCES (PTY) LTD | active | Jan 1900 |
| MYLAN OXYBUTYNIN 5 | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| SPASTYNIN Extended Release Tablet | 🇹🇿Tanzania | UNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd) | active | — |
Oxybutynin Chloride in Africa — Regulatory Overview
Oxybutynin Chloride is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.